Sources close to the development said that, in addition to Zydus Group, RDIF is also in talks with three other companies in India to increase the supply of Sputnik V doses in India.
After Dr. Reddy’s Labs, Gujarat-based Zydus Cadila also learned that he is in talks with the Russian Direct Investment Fund (RDIF) to bring the Sputnik V coronavirus vaccine to India.
Sources close to the development said that in addition to the Zydus Group, RDIF is also in talks with three other companies in India to increase the supply of Sputnik V doses in India.
RDIF and Dr Reddy’s Laboratories have teamed up on Sputnik V clinical trials and distribution in India. The Indian drugmaker would also conduct phase 3 clinical trials in the country for the vaccine.
“RDIF agreed to supply 10 crore doses of the world’s first coronavirus vaccine to Dr. Reddy’s laboratories. However, he wanted to increase the supply of the vaccine and therefore started discussions with at least four Indian drug manufacturers, including that of Zydus Cadila. In fact, the Gujarat-based company is in advanced stages of talks with RDIF, ”the sources said.
Zydus is already working on its Covid-19 vaccine proposal. The company is in the process of leveraging the approvals to conduct phase 3 clinical trials. Sources at Zydus said it got encouraging results during the animal testing phase.
RDIF has recently said that it would carry out phase 3 trials in India for Sputnik V to ensure safety and efficacy for the local population and also to meet the requirements of Indian regulators. According to sources, Zydus is already working on a Covid-19 vaccine and it would be a win-win situation for both Zydus and RDIF.
RDIF wants to deliver the coronavirus vaccine by the end of 2020 and to that end would require the cooperation of more than one local pharmaceutical company that has infrastructure for clinical trials and markets it in India in large quantities.
The Sputnik V vaccine, which has been developed by the Gamaleya National Research Institute of Epidemiology and Microbiology, was registered by the Russian Ministry of Health in August 2020 and has become the world’s first registered vaccine against Covid-19. based on the human adenoviral vector platform. .
Get Live Stock Prices from BSE, NSE, US Market & Latest NAV, Mutual Fund Portfolio, Calculate Your Taxes with Income Tax Calculator, Learn Top Winners, Top Losers, and Top market capital funds. Like us on Facebook and follow us on Twitter.
Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest news and updates from Biz.
.
